| Dr Katrina H Walsh, MD | |
|
1600 Coit Rd, Suite 402, Plano, TX 75075-6174 | |
| (972) 519-1900 | |
| (972) 964-5323 |
| Full Name | Dr Katrina H Walsh |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1600 Coit Rd, Plano, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073502563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | J1422 (Texas) | Primary |
| Entity Name | Karan R Moseley |
|---|---|
| Entity Type | Practitioner - Obstetrics/gynecology |
| Entity Identifiers | NPI Number: 1568416188 PECOS PAC ID: 0345286266 Enrollment ID: I20050826000519 |
News Archive
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
The U.S. Surgeon General's office estimates that more than 20 million people have a substance use disorder. Meanwhile, the nation's drug overdose crisis shows no sign of slowing.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
› Verified 1 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
The U.S. Surgeon General's office estimates that more than 20 million people have a substance use disorder. Meanwhile, the nation's drug overdose crisis shows no sign of slowing.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
› Verified 1 days ago
| Entity Name | Arlington Physician Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093144610 PECOS PAC ID: 8224256961 Enrollment ID: O20140821002133 |
News Archive
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
The U.S. Surgeon General's office estimates that more than 20 million people have a substance use disorder. Meanwhile, the nation's drug overdose crisis shows no sign of slowing.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katrina H Walsh, MD 1600 Coit Rd, Suite 402, Plano, TX 75075-6174 Ph: (972) 519-1900 | Dr Katrina H Walsh, MD 1600 Coit Rd, Suite 402, Plano, TX 75075-6174 Ph: (972) 519-1900 |
News Archive
A group of prevention-focused healthcare organizations has expressed deep concern over recently-proposed restrictions to OHIP coverage of Vitamin D testing in the province. The proposed new legislation will delist OHIP insured Vitamin D testing for most Ontarians. Exceptions will be made for those with osteoporosis, malabsorption syndromes, and individuals taking medications that interfere with vitamin D absorption or metabolism.
The U.S. Surgeon General's office estimates that more than 20 million people have a substance use disorder. Meanwhile, the nation's drug overdose crisis shows no sign of slowing.
Much of what we thought we knew about the human papilloma virus (HPV) in HPV-related head and neck cancers may be wrong, according to a newly published study by Virginia Commonwealth University researchers that analyzed data from The Human Cancer Genome Atlas.
AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
› Verified 1 days ago
Dr. Christy Washington Walker, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6130 W Parker Rd Ste 204, Plano, TX 75093 Phone: 972-981-7861 Fax: 972-981-7862 | |
Surekha Machupalli, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8901 Independence Pkwy, Plano, TX 75025 Phone: 972-908-2444 | |
Dr. Arlene Esther Garcia-soto, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6957 W Plano Pkwy Ste 2000, Plano, TX 75093 Phone: 214-483-6933 Fax: 214-483-6648 | |
Dr. Nora L Hsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 280, Plano, TX 75024 Phone: 972-867-6400 | |
Madhuri Gudipaty, M.D Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 Coit Rd, Suite 101, Plano, TX 75075 Phone: 972-867-7500 Fax: 972-578-7550 | |
Carol L. Brown-elliott, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3901 W 15th St, #200, Plano, TX 75075 Phone: 972-519-1328 |